EU Pushes For Compulsory Licensing Of Drugs & Vaccines In Health Crises
Activists Welcome 'Surprise' Move But Industry Disappointed
Executive Summary
The EU has published an action plan that is intended to upgrade the bloc’s intellectual property framework while ensuring that goods such as medicines and vaccines are made as widely available as possible. The initiative is part of wide-ranging plans to support member states’ recovery from the pandemic crisis and help ensure the EU’s resilience to future health threats.
You may also be interested in...
Industry Skeptical Of EU Moves To Facilitate Compulsory Licensing
Industry representatives in the EU are more welcoming of moves to harmonize supplementary protection certificates, which they say will bring more certainty for stakeholders.
EU Reveals Plans For Unitary SPC & Review Of Compulsory Licensing
The EU has announced two separate legal initiatives, one that would improve IP protections, and another that could weaken them in the event of a future health crisis.
EU Reveals Plans For Unitary SPC & Review Of Compulsory Licensing
The EU has announced two separate legal initiatives, one that would improve IP protections, and another that could weaken them in the event of a future health crisis.